VA
ACH

Vident Advisory’s Accendra Health ACH Stock Holding History

Vident Advisory’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,685
Closed -$75.3K – 1706
2025
Q3 		$75.3K Sell
15,685
-8,616
-35% -$54.8K ﹤0.01% 1611
2025
Q2 		$221K Buy
24,301
+4,964
+26% +$36.6K ﹤0.01% 1461
2025
Q1 		$175K Buy
+19,337
New +$204K ﹤0.01% 1464
2024
Q4 		– Sell
-12,766
Closed -$200K – 1521
2024
Q3 		$200K Buy
+12,766
New +$193K 0.01% 1325
2024
Q2 		– Sell
-8,362
Closed -$232K – 1486
2024
Q1 		$232K Buy
+8,362
New +$186K ﹤0.01% 1151

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vident Advisory's ACH Position: Q4 2025 in Review

Vident Advisory sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 15,685 shares — an estimated $75.3K sold.

Vident Advisory first reported a position in ACH in Q1 2024 and held it in 5 quarters. The position peaked at $232K in Q1 2024. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Vident Advisory reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • Vident Advisory sold 15,685 Accendra Health shares in Q4 2025, an estimated $75.3K.
  • Vident Advisory first reported a position in Accendra Health in Q1 2024 and held it in 5 quarters.
  • Vident Advisory's Accendra Health position peaked at $232K in Q1 2024.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.